GlassScriptPhysician profile
Robert Emmett Pollard
NPI 1952341158
$670.42
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $183 · 2021: $75.92 · 2022: $14.71.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $132.83 | 2019-2020 | |
| Optinose US, INC. | $123.24 | 2019-2021 | |
| Genzyme Corporation | $121.28 | 2019 | |
| Phadia US INC. | $84.38 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $84.05 | 2019 | |
| Acclarent, INC | $72.18 | 2019-2021 | |
| Aerin Medical INC. | $37.75 | 2019-2020 | |
| Stryker Corporation | $14.71 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pollard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.